CAD 0.1
(-9.09%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.00 CAD | -5.0% |
2022 | -0.00 CAD | -263.64% |
2021 | -0.00 CAD | -266.67% |
2020 | -0.00 CAD | 40.0% |
2019 | -0.00 CAD | 16.67% |
2018 | -0.00 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.00 CAD | 58.33% |
2024 Q1 | -0.00 CAD | 0.0% |
2024 Q3 | -0.00 CAD | -60.0% |
2023 FY | - CAD | -5.0% |
2023 Q4 | -0.00 CAD | 14.29% |
2023 Q2 | -0.00 CAD | 54.55% |
2023 Q1 | -0.00 CAD | 26.67% |
2023 Q3 | -0.00 CAD | -180.0% |
2022 Q4 | -0.00 CAD | -200.0% |
2022 Q3 | -0.00 CAD | 54.55% |
2022 Q2 | -0.00 CAD | 0.0% |
2022 Q1 | -0.00 CAD | -450.0% |
2022 FY | - CAD | -263.64% |
2021 Q2 | -0.00 CAD | 0.0% |
2021 FY | - CAD | -266.67% |
2021 Q4 | -0.00 CAD | 0.0% |
2021 Q3 | -0.00 CAD | 33.33% |
2020 FY | - CAD | 40.0% |
2019 FY | - CAD | 16.67% |
2018 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Biosenta Inc. | -0.24 CAD | 98.25% |